Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Journey Medical (DERM) Asset Utilization Ratio (2021 - 2025)

Journey Medical (DERM) has disclosed Asset Utilization Ratio for 5 consecutive years, with 0.71 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Asset Utilization Ratio rose 19.41% year-over-year to 0.71, compared with a TTM value of 0.71 through Sep 2025, up 19.41%, and an annual FY2024 reading of 0.71, up 9.01% over the prior year.
  • Asset Utilization Ratio was 0.71 for Q3 2025 at Journey Medical, up from 0.68 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 1.17 in Q3 2023 and bottomed at 0.59 in Q3 2024.
  • Average Asset Utilization Ratio over 5 years is 0.75, with a median of 0.69 recorded in 2022.
  • The sharpest move saw Asset Utilization Ratio surged 72.96% in 2023, then crashed 49.57% in 2024.
  • Year by year, Asset Utilization Ratio stood at 0.68 in 2021, then grew by 1.88% to 0.69 in 2022, then rose by 20.65% to 0.83 in 2023, then decreased by 6.57% to 0.78 in 2024, then fell by 9.16% to 0.71 in 2025.
  • Business Quant data shows Asset Utilization Ratio for DERM at 0.71 in Q3 2025, 0.68 in Q2 2025, and 0.68 in Q1 2025.